| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rafael Holdings, Inc. | Chief Operating Officer | Class B Common Stock, per value $.01 per share | 9.38K | $13.8K | $1.47 | Sep 3, 2025 | Direct |
| Cyclo Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 111K | Jun 3, 2024 | Direct | ||
| Rafael Holdings, Inc. | Chief Operating Officer | Stock Options (right to buy) | 24.6K | Sep 3, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RFL | Rafael Holdings, Inc. | Sep 3, 2025 | 1 | $0 | 4 | Sep 5, 2025 | Chief Operating Officer |
| RFL | Rafael Holdings, Inc. | Aug 4, 2025 | 0 | $0 | 3 | Aug 11, 2025 | Chief Operations Officer |
| CYTH | Cyclo Therapeutics, Inc. | Jun 3, 2024 | 1 | $0 | 4 | Jun 5, 2024 | Chief Financial Officer |
| CYTH | Cyclo Therapeutics, Inc. | Mar 7, 2023 | 1 | $0 | 4 | Mar 9, 2023 | Chief Financial Officer |
| CYTH | Cyclo Therapeutics, Inc. | Feb 28, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Chief Financial Officer |
| CYTH | Cyclo Therapeutics, Inc. | Aug 27, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Chief Financial Officer |